Moore F A, Moore E E, Moore G E, Millikan J S
Am J Surg. 1984 Dec;148(6):800-5. doi: 10.1016/0002-9610(84)90441-0.
This review was undertaken to analyze critically the complications resulting from operative splenic salvage. Over a 6 year period, 200 adults who sustained splenic trauma underwent laparotomy. The mechanism of injury was blunt in 138 patients (69 percent), a stab wound in 32 patients (16 percent), and a gunshot wound in 30 patients (15 percent). Splenorrhaphy was accomplished in 85 patients (42 percent). Methods of repair included cautery and hemostatic agents in 24 patients (28 percent), debridement and suturing in 42 patients (50 percent), and partial resection in 19 patients (22 percent). Six patients died, four from head trauma and two from multiple organ failure. Postoperative complications occurred in 14 patients. Four were intraabdominal. Three patients required reoperation for splenic hemorrhage; one (2 percent) after suture repair and two (11 percent) after partial resection. A left subphrenic abscess developed in another patient. Splenic reimplantation was performed in 43 patients (22 percent). Five deaths occurred. One was due to head trauma, three to multiple organ failure, and one to overwhelming pneumococcal infection. Eleven postoperative complications occurred, but none was related to splenic autotransplantation. Despite the enthusiasm for splenic salvage, the number of patients suitable for splenorrhaphy plateaued at 56 percent. Complications of splenorrhaphy are infrequent, and the risk increases with more complex salvage attempts. We believe that splenic reimplantation remains a safe procedure.
本综述旨在批判性分析手术保脾所致的并发症。在6年期间,200例脾外伤的成人接受了剖腹手术。损伤机制为钝性伤138例(69%),刺伤32例(16%),枪伤30例(15%)。85例(42%)患者实施了脾修补术。修复方法包括24例(28%)使用烧灼和止血剂,42例(50%)清创缝合,19例(22%)部分切除。6例患者死亡,4例死于头部外伤,2例死于多器官功能衰竭。14例患者发生术后并发症。4例为腹腔内并发症。3例患者因脾出血需要再次手术;1例(2%)在缝合修复后,2例(11%)在部分切除后。另1例患者发生左膈下脓肿。43例(22%)患者进行了脾再植。5例患者死亡。1例死于头部外伤,3例死于多器官功能衰竭,1例死于暴发性肺炎球菌感染。发生了11例术后并发症,但均与脾自体移植无关。尽管对保脾充满热情,但适合脾修补术的患者数量稳定在56%。脾修补术的并发症并不常见,随着保脾尝试的复杂性增加,风险也会增加。我们认为脾再植仍然是一种安全的手术。